The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996.
Katherine L O'Brien; Jana Shaw; Robert Weatherholtz; Raymond Reid; James Watt; Janne Croll; Ron Dagan; Alan J Parkinson; Mathuram Santosham (Profiled Authors: James Watt; Raymond Reid; Katherine O'Brien; Mathuram Santosham)
Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. email@example.com
American journal of epidemiology 2004;160(3):270-8.
Streptococcus pneumoniae is the most common cause of invasive bacterial disease among children worldwide. The authors aimed to determine the incidence, clinical characteristics, and serotype distribution of invasive pneumococcal disease (IPD) among Navajo children in the southwestern United States. Active population-based laboratory surveillance for IPD among resident members of the Navajo Nation under 18 years of age was conducted between 1989 and 1996. During this 8-year period, 706 cases of IPD were identified. The rate of disease varied by age, with the highest rate being observed among children aged 6-11 months (727 cases/100,000 person-years), followed by children aged 0-11 months, 0-23 months, and 0-59 months (568, 537, and 272 cases/100,000 person-years, respectively). Among children aged 0-23 months, 60.3% of cases were caused by serotypes in the seven-valent conjugate pneumococcal vaccine (71.5% from 1989-1993 and 58.3% from 1994-1996). Navajo children are at increased risk of IPD in comparison with the general US population. The distribution of disease-causing serotypes is similar to that of many countries in the developing world. Prevention strategies should include the use of licensed pneumococcal protein conjugate vaccine; however, a substantial proportion of disease is caused by nonvaccine serotypes. These data are critical for assessing the impact of these vaccines in this high-risk population.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Rochelle Lacapa; Sandra J Bliss; Francene Larzelere-Hinton; Kathryn J Eagle; Debra J McGinty; Alan J Parkinson; Mathuram Santosham; Mariddie J Craig; Katherine L O'BrienClinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(4):476-84.
Jennifer R Scott; William P Hanage; Marc Lipsitch; Eugene V Millar; Lawrence H Moulton; Jason Hinds; Raymond Reid; Mathuram Santosham; Katherine L O'BrienVaccine 2012;30(13):2376-81.
Andrea L Benin; James P Watt; Katherine L O'Brien; Raymond Reid; Elizabeth R Zell; Scott Katz; Connie Donaldson; Anne Schuchat; Mathuram Santosham; Cynthia G WhitneyHuman vaccines 2005;1(2):66-9.
Appears in this Publication
Author of this Publication